WebAcquisition significantly expands Flagship’s portfolio of biomarker and analytics services BROOMFIELD, Colo., August 31, 2024—Flagship Biosciences, Inc., a leader in spatial … WebIn July of 2024, the Company acquired the biopharma services division of Cancer Genetics, Inc., renaming this acquisition Interpace Pharma Solutions and changing the holding company name to Interpace Biosciences. Interpace Pharma Solutions was sold to Flagship Biosciences in August, 2024. The public company status remains the same …

Interpace Pharma Solutions Announces New Capability in Spatial …

WebA. Interpace Biosciences, Inc., a Delaware corporation, Interpace Diagnostics Corporation, a Delaware corporation, Interpace Diagnostics, LLC, a Delaware limited liability company and Interpace Pharma Solutions, Inc., a Delaware corporation (individually and collectively, “Borrower”) has requested and/or obtained certain loans or other credit … WebAug 31, 2024 · Interpace Transitions to focused Molecular Diagnostics Business; Disposition of Pharma Services Expected to Improve Operating Cash Flow by nearly $5 … it support green bay

Spatial Biology CRO Flagship Biosciences Acquires Pharma …

WebInterpace Pharma Solutions, Inc. NFS Leasing, Inc. People’s United Bank, N.A : Equipment or Software as described in the Schedule 1 to Master Lease Agreement 2024 … WebIn July of 2024, the Company acquired the biopharma services division of Cancer Genetics, Inc., renaming this acquisition Interpace Pharma Solutions and changing the holding … WebInterpace Pharma Solutions, Inc. NFS Leasing, Inc. People’s United Bank, N.A : Equipment or Software as described in the Schedule 1 to Master Lease Agreement 2024-0281 : Interpace Pharma Solutions, Inc. Collateral (Section 5.3) Deposit or Securities Accounts . Institution Name : it support hastings